AHCC News

Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group initiates Collaborative partnership in hope to develop new HCC therapies 

Click here to read.
National Cancer Centre Singapore

Interim analysis found SGH-led SIRveNIB regional phase III clinical trial to treat patients with locally advanced liver cancer right on track 

Click here to read.
Singapore General Hospital

New wonder treatment for liver cancer (Wijeya Newspapers Ltd, Colombo, Sri Lanka)

Click here to read.
Singapore General Hospital

防肝癌 也需防 脂肪肝(LianHe WanBao)

Click here to read. 
Singapore General Hospital

New Cancer Treatment Gives New Lease of Life (The Straits Times)

Click here to read. 
Singapore General Hospital

体内放射疗法 可治多种肝癌 (LianHe WanBao)

Click here to read. 
Singapore General Hospital

Novel combination of two existing therapeutics shows promising activity in patients with advanced liver cancer 

An Interview with Prof Pierce Chow and Dr Choo Su Pin on AHCC05 Study: Phase I/II Study of SIR-Spheres plus Sorafenib (Chemo-Radiotherapy) as first line treatment in patients with non-resectable primary hepatocellular carcinoma. 

By Medical Grapevine >> Read the AHCC05 article

Record Funding for Liver Cancer Drugs Test (The Straits Times)

Click here to read.  
Singapore General Hospital

Life span of inoperable advanced liver cancer patients may be extended by 9 months or more with combined treatment. 

Click here to read. 
National Cancer Centre Singapore

New Trials give Hope to Liver Cancer Patients (The Straits Times)

Click here to read. 
Singapore General Hospital

Singapore benefits in economic and social spin-offs from medical scientific community playing key role in mega clinical trials 

Click here to read.
National Cancer Centre Singapore